Cell Death Society Symposium on Targeting Cell Death Pathways for Human Diseases

申请者描述(申请人提供)：本申请申请资助将于2008年6月6-9日在上海国家会计学院中国举行的细胞死亡国际会议。这次会议的主题是“针对人类疾病的细胞死亡途径”。由于中国和日本的基础研究和有针对性的临床研究之间的密切互动，这个地点特别适合作为美国科学家可以学习新方法并在广泛兴趣范围内有效互动的地点。我们的会议将讨论调整和触发细胞死亡决定的方式。这些主题对老年学、免疫学、神经学和肿瘤学领域特别感兴趣。有了这些考虑以及干预的特定靶向的需要，现在是将来自几个国家的基础研究人员、临床医生和药物研究人员聚集在一起的最好时机。将有两个海报会议。新兴科学家通过在受邀演讲的战略要点上穿插简短的演讲而获得良好的曝光率，这些演讲从提交的摘要中挑选出来。日程安排适应了中国的风俗习惯，为正式和非正式的讨论和社交提供了充足的时间。我们会议的一个重要方面是总结谈话，总结主要的新发现，追踪新出现的趋势，并为未来的趋势提供指导。我们的会议将讨论如何从基础研究转向治疗干预和针对人类疾病的细胞死亡途径的方法的开发。

DESCRIPTION (provided by applicant): This application requests funds to support the International Conference on Cell Death, to be held at Shanghai National Accounting Institute, Shanghai, China, June 6-9 2008. The theme of the conference will be "Targeting cell death pathways for human diseases". Because of the close interaction between basic research and targeted clinical research in China and Japan, this locale is particularly suitable as a site at which US scientists can learn new approaches and interact effectively across a broad spectrum of interests. Our meeting will address the means by which the decision of a cell to die is modulated and triggered. These topics are of particular interest to the fields of gerontology, immunology, neurology, and oncology. With these considerations as well as the need for specific targeting of intervention, this is a most propitious time to bring together basic researchers, clinicians, and pharmaceutical researchers from several nations. There will be two poster sessions. Emerging scientists are given good exposure by interspersing short talks, chosen from submitted abstracts, at strategic points among the invited talks. The schedule is adapted to the customs of China and allows ample time for formal and informal discussions and socializing. An important aspect of our meetings has been a wrap-up talk, which summarizes the major new findings, traces emerging trends, and provides guidance for future trends. Our meeting will address the idea of how to go from basic research to development of methods for therapeutic interventions and targeting cell death pathways for human diseases.